BioCentury | Mar 6, 2006
Company News

LCT board of directors update

...Ltd. (ASX:LCT), Melbourne, Australia Business: Gene/Cell therapy Appointed: Charles Macek, former managing director at County Natwest...
BioCentury | Mar 5, 2001
Finance

Ebb & Flow

...primarily in the U.K., but also in Europe and the U.S. Investors include Abbey National; NatWest...
BioCentury | Feb 14, 2000
Finance

Pessimists could be nervous

...life sciences offerings. The company intends to raise £25 million ($40 million), with 3i and NatWest...
BioCentury | Feb 26, 1996
Analyst Picks & Changes

Analyst picks & changes

...Mycogen Corp. (MYCO), San Diego, Calif. Business: Agbio NatWest Securities analyst Mark Wiltamuth began coverage with...
Items per page:
1 - 4 of 4
BioCentury | Mar 6, 2006
Company News

LCT board of directors update

...Ltd. (ASX:LCT), Melbourne, Australia Business: Gene/Cell therapy Appointed: Charles Macek, former managing director at County Natwest...
BioCentury | Mar 5, 2001
Finance

Ebb & Flow

...primarily in the U.K., but also in Europe and the U.S. Investors include Abbey National; NatWest...
BioCentury | Feb 14, 2000
Finance

Pessimists could be nervous

...life sciences offerings. The company intends to raise £25 million ($40 million), with 3i and NatWest...
BioCentury | Feb 26, 1996
Analyst Picks & Changes

Analyst picks & changes

...Mycogen Corp. (MYCO), San Diego, Calif. Business: Agbio NatWest Securities analyst Mark Wiltamuth began coverage with...
Items per page:
1 - 4 of 4